Physician profile
David P Timler
NPI 1154641025
$555.95
in general payments reported to CMS, 2019-2025
18 companies · $26.93 in 2025
The $26.93 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515 · 2023: $13.89 · 2025: $26.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26.93 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $26.93 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $120.15 | 2019 | |
| Amgen INC. | $60.95 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.52 | 2019 | |
| Novo Nordisk INC | $43.16 | 2019 | |
| Shire North American Group INC | $28.32 | 2019 | |
| Sanofi Pasteur INC. | $26.93 | 2025 | |
| Astellas Pharma US INC | $26.85 | 2019 | |
| Allergan, INC. | $26.21 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.48 | 2019 | |
| Amarin Pharma, INC. | $25.11 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.59 | 2019 | |
| Radius Health, INC. | $17.59 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.72 | 2019 | |
| Tris Pharma INC | $14.28 | 2019 | |
| Lilly USA, LLC | $12.90 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $12.34 | 2019 | |
| Merck Sharp & Dohme LLC | $11.69 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Timler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.